0001384101-19-000036.txt : 20190412
0001384101-19-000036.hdr.sgml : 20190412
20190412165114
ACCESSION NUMBER: 0001384101-19-000036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190411
FILED AS OF DATE: 20190412
DATE AS OF CHANGE: 20190412
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hall Christopher M
CENTRAL INDEX KEY: 0001449535
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36156
FILM NUMBER: 19746838
MAIL ADDRESS:
STREET 1: 1401 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERACYTE, INC.
CENTRAL INDEX KEY: 0001384101
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 205455398
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 243-6300
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: CALDEROME INC
DATE OF NAME CHANGE: 20061219
4
1
wf-form4_155510225985847.xml
FORM 4
X0306
4
2019-04-11
0
0001384101
VERACYTE, INC.
VCYT
0001449535
Hall Christopher M
6000 SHORELINE COURT
SUITE 300
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
President and COO
Common Stock
2019-04-11
4
M
0
17927
2.68
A
46641
D
Common Stock
2019-04-11
4
M
0
43017
4
A
89658
D
Common Stock
2019-04-11
4
M
0
19056
5.98
A
108714
D
Common Stock
2019-04-11
4
S
0
75164
25.0916
D
33550
D
Common Stock
2019-04-11
4
S
0
4836
25.5787
D
28714
D
Stock Option (right to buy)
2.68
2019-04-11
4
M
0
17927
0
D
2022-03-09
Common Stock
17927.0
0
D
Stock Option (right to buy)
4.0
2019-04-11
4
M
0
43017
0
D
2023-02-04
Common Stock
43017.0
0
D
Stock Option (right to buy)
5.98
2019-04-11
4
M
0
19056
0
D
2028-03-01
Common Stock
19056.0
91194
D
The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019.
Represents weighted average sales price. Sale prices for the transactions range from $24.55 to $25.54. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Represents weighted average sales price. Sale prices for the transactions range from $25.55 to $25.60. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
The option is fully vested.
The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
/s/ Keith Kennedy, as Attorney-in-fact
2019-04-12